Deutsche Bank’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,800
Closed -$803K 3727
2026
Q1
$803K Buy
+3,800
New +$818K ﹤0.01% 2310
2025
Q4
Sell
-111,600
Closed -$17.5M 3639
2025
Q3
$17.5M Buy
+111,600
New +$17.2M 0.01% 894
2024
Q4
Sell
-64,200
Closed -$7.1M 3621
2024
Q3
$7.1M Buy
+64,200
New +$6.71M ﹤0.01% 1135
2023
Q3
Sell
-1,060
Closed -$100K 3721
2023
Q2
$100K Buy
+1,060
New +$89.5K ﹤0.01% 3273
2023
Q1
Sell
-611
Closed -$47K 3921
2022
Q4
$47K Sell
611
-8,866
-94% -$674K ﹤0.01% 3598
2022
Q3
$632K Buy
+9,477
New +$601K ﹤0.01% 2248
2021
Q3
Sell
-108
Closed -$6K 4421
2021
Q2
$6K Sell
108
-1
-0.9% -$58 ﹤0.01% 4494
2021
Q1
$7K Buy
+109
New +$6.02K ﹤0.01% 4452
2016
Q3
Sell
-400
Closed -$31K 4932
2016
Q2
$31K Buy
+400
New +$31.9K ﹤0.01% 4601

Other funds holding CAH

Deutsche Bank's CAH Position: Q2 2026 in Review

Deutsche Bank reduced its Cardinal Health (CAH) stake by 1.9% in Q2 2026, selling an estimated $4.03M and leaving 1,005,780 shares worth $239M. The position accounts for 0.07% of the portfolio, ranked #250.

Deutsche Bank first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $250M in Q4 2013. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Deutsche Bank held 1,005,780 shares of Cardinal Health worth $239M as of Q2 2026.
  • Deutsche Bank sold 19,400 Cardinal Health shares in Q2 2026, an estimated $4.03M.
  • Cardinal Health made up 0.07% of Deutsche Bank's portfolio in Q2 2026, its #250 holding.
  • Deutsche Bank first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Cardinal Health position peaked at $250M in Q4 2013.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.